// App-Quantinova.ai

3274 : Steroid Use, Advanced Stage Disease and ≥3 Lines of Prior Chemotherapy Are Associated with a Higher Risk of Infection Following CD19 CAR T-Cell Therapy for B-NHL: Real World Data from a Large UK Center

Researchers

Presenter

  • Lorna Neill

Principal Investigators

  • Strachan C Mackenzie

  • Maria A V Marzolini

  • William Townsend

  • Kirit M. Ardeshna

  • Kate Cwynarski

  • Surjo De

  • Vanya Gant

  • Lhara Mure

  • Sara McElduff

  • Chantelle Hughes

  • Karl S Peggs

  • Claire Roddie

  • Maeve A O'Reilly

Medical Centers

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Haematology, University College London Hospitals NHS Foundation Trust (UCLH), London, United Kingdom

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • Department of Haematology, Clinical Lead, CAR-T, University College London Hospitals Senior Lecturer in Haematology, University College London NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Invasive fungal infection

Biomarkers

  • Cluster of Differentiation 19

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved